scholarly journals Bayesian inference on the number of recurrent events: A joint model of recurrence and survival

2021 ◽  
pp. 096228022110480
Author(s):  
Willem van den Boom ◽  
Maria De Iorio ◽  
Marta Tallarita

The number of recurrent events before a terminating event is often of interest. For instance, death terminates an individual’s process of rehospitalizations and the number of rehospitalizations is an important indicator of economic cost. We propose a model in which the number of recurrences before termination is a random variable of interest, enabling inference and prediction on it. Then, conditionally on this number, we specify a joint distribution for recurrence and survival. This novel conditional approach induces dependence between recurrence and survival, which is often present, for instance, due to frailty that affects both. Additional dependence between recurrence and survival is introduced by the specification of a joint distribution on their respective frailty terms. Moreover, through the introduction of an autoregressive model, our approach is able to capture the temporal dependence in the recurrent events trajectory. A non-parametric random effects distribution for the frailty terms accommodates population heterogeneity and allows for data-driven clustering of the subjects. A tailored Gibbs sampler involving reversible jump and slice sampling steps implements posterior inference. We illustrate our model on colorectal cancer data, compare its performance with existing approaches and provide appropriate inference on the number of recurrent events.

2018 ◽  
Vol 12 (2) ◽  
pp. 391-411
Author(s):  
Maissa Tamraz

AbstractIn the classical collective model over a fixed time period of two insurance portfolios, we are interested, in this contribution, in the models that relate to the joint distributionFof the largest claim amounts observed in both insurance portfolios. Specifically, we consider the tractable model where the claim counting random variableNfollows a discrete-stable distribution with parameters (α,λ). We investigate the dependence property ofFwith respect to both parametersαandλ. Furthermore, we present several applications of the new model to concrete insurance data sets and assess the fit of our new model with respect to other models already considered in some recent contributions. We can see that our model performs well with respect to most data sets.


2018 ◽  
Vol 28 (8) ◽  
pp. 2385-2403 ◽  
Author(s):  
Tobias Mütze ◽  
Ekkehard Glimm ◽  
Heinz Schmidli ◽  
Tim Friede

Robust semiparametric models for recurrent events have received increasing attention in the analysis of clinical trials in a variety of diseases including chronic heart failure. In comparison to parametric recurrent event models, robust semiparametric models are more flexible in that neither the baseline event rate nor the process inducing between-patient heterogeneity needs to be specified in terms of a specific parametric statistical model. However, implementing group sequential designs in the robust semiparametric model is complicated by the fact that the sequence of Wald statistics does not follow asymptotically the canonical joint distribution. In this manuscript, we propose two types of group sequential procedures for a robust semiparametric analysis of recurrent events. The first group sequential procedure is based on the asymptotic covariance of the sequence of Wald statistics and it guarantees asymptotic control of the type I error rate. The second procedure is based on the canonical joint distribution and does not guarantee asymptotic type I error rate control but is easy to implement and corresponds to the well-known standard approach for group sequential designs. Moreover, we describe how to determine the maximum information when planning a clinical trial with a group sequential design and a robust semiparametric analysis of recurrent events. We contrast the operating characteristics of the proposed group sequential procedures in a simulation study motivated by the ongoing phase 3 PARAGON-HF trial (ClinicalTrials.gov identifier: NCT01920711) in more than 4600 patients with chronic heart failure and a preserved ejection fraction. We found that both group sequential procedures have similar operating characteristics and that for some practically relevant scenarios, the group sequential procedure based on the canonical joint distribution has advantages with respect to the control of the type I error rate. The proposed method for calculating the maximum information results in appropriately powered trials for both procedures.


2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Wenjun Xiong ◽  
Hongyu Lu ◽  
Juan Ding

Pooling is an attractive strategy in screening infected specimens, especially for rare diseases. An essential step of performing the pooled test is to determine the group size. Sometimes, equal group size is not appropriate due to population heterogeneity. In this case, varying group sizes are preferred and could be determined while individual information is available. In this study, we propose a sequential procedure to determine varying group sizes through fully utilizing available information. This procedure is data driven. Simulations show that it has good performance in estimating parameters.


2018 ◽  
Vol 55 (2) ◽  
pp. 488-512 ◽  
Author(s):  
Laure Coutin ◽  
Monique Pontier ◽  
Waly Ngom

Abstract Let X be a jump-diffusion process and X* its running supremum. In this paper we first show that for any t > 0, the law of the pair (X*t, Xt) has a density with respect to the Lebesgue measure. This allows us to show that for any t > 0, the law of the pair formed by the random variable Xt and the running supremum X*t of X at time t can be characterized as a weak solution of a partial differential equation concerning the distribution of the pair (X*t, Xt). Then we obtain an expression of the marginal density of X*t for all t > 0.


2021 ◽  
Author(s):  
Azadeh Fakhrzadeh

In this thesis, the problem of data denoising is considered and a new data denoising method is developed. This approach is an adaptive, data-driven thresholding method that is based on Minimum Noiseless Description Length (MNDL). MNDL is an approach to subspace selection which estimates bounds on the desired Mean Square Error (MSE). The subspace minimizing these bounds is chosen as the optimum one. In this research, we explore application of MNDL Subspace Selection (MNDL-SS) as a thresholding method. Although the basic idea and desired criterion of MNDL thresholding and MNDL-SS are the same, the challenges in calculation of the desired criterion in MNDL thresholding are very different. In MNDL-SS, the additive noise effects are in the form of samples of a Chi-Square random variable. However, this assumption does not hold for MNDL thresholding anymore. In this research, we developed a new method for calculation of the desired criterion based on characteristics of noise in thresholding. Our simulation results show that MNDL thresholding outperforms the compared methods. In this thesis, we also explore the area of image denoising. In image denoising approaches, some properties of the image are considered. One of the well known image denoising methods, that outperforms other methods, is BayesShrink. We compare our method with BayesShrink. We show that the results of MNDS thresholding are comparable with BayesShrink in our simulations.


2015 ◽  
Vol 33 (29_suppl) ◽  
pp. 185-185
Author(s):  
Isabelle Borget ◽  
Alexandre Vainchtock ◽  
Nicolas Martelli ◽  
Florian Scotte

185 Background: Venous thromboembolic event (VTE) is a common complication for cancer patients, leading to hospitalizations that increase the burden of cancer management. Our study aimed to estimate the incidence and costs of hospitalizations for VTE, in French patients with breast cancer (BC), colon cancer (CC), lung cancer (LC) or prostate cancer (PC), four of the most frequent cancers in France. Methods: We used the French national hospital database (PMSI) to select new patients with BC, CC, LC or PC in 2010, who had at least one VTE-related hospitalization during the following two years. VTE-related stays and patients were identified using the disease-specific ICD-10 codes. Hospital costs were calculated over stays for which VTE was considered as primary/related diagnosis. Costs were estimated from the healthcare system perspective, using the French official tariffs. Results: Among 194,964 patients newly diagnosed in 2010 with BC, CC, LC or PC in 2010, 8,909 (4.6%) were hospitalized for a VTE or experienced VTE at hospital, representing, 12,880 hospital stays. During the two-year follow-up, 2,053 (23.0%) patients were re-hospitalized for a VTE recurrence, representing 3,969 stays (30.8% of admissions for VTE). For one patient with VTE who did not experience recurrence, the mean hospital cost over two years ranged from €3,302 to €3,674. This amount was dramatically increased for patients with recurrent VTE, as it ranged from €5,441 to €5,692 per patient. Hospitalizations for VTE associated with those 4 types of cancer only were responsible for an overall expenditure reaching €13.30 million over two years, including €1.82 million due to recurrent events. Conclusions: VTE-related cancer hospitalizations remain frequent and induce a notable cost. Prevention and management in respect to guidelines would be an efficient way to reduce the incidence of this complication and moderate its economic cost. [Table: see text]


Author(s):  
Praveen Kokkerapati ◽  
Abeer Alsadoon ◽  
SMN Arosha Senanayake ◽  
P. W. C. Prasad ◽  
Abdul Ghani Naim ◽  
...  

2020 ◽  
Author(s):  
Elaheh Talebi‐Ghane ◽  
AhmadReza Baghestani ◽  
Farid Zayeri ◽  
Virgine Rondeau ◽  
Ali Akhavan

Sign in / Sign up

Export Citation Format

Share Document